高级检索
    郭姗姗, 王贺, 李明新. 常规治疗联合0.01%次氯酸治疗睑板腺功能障碍的临床观察[J]. 徐州医科大学学报, 2022, 42(7): 503-507. DOI: 10.3969/j.issn.2096-3882.2022.07.007
    引用本文: 郭姗姗, 王贺, 李明新. 常规治疗联合0.01%次氯酸治疗睑板腺功能障碍的临床观察[J]. 徐州医科大学学报, 2022, 42(7): 503-507. DOI: 10.3969/j.issn.2096-3882.2022.07.007
    Clinical observation of conventional treatment combined with 0.01% hypochlorous acid on meibomian gland dysfunction[J]. Journal of Xuzhou Medical University, 2022, 42(7): 503-507. DOI: 10.3969/j.issn.2096-3882.2022.07.007
    Citation: Clinical observation of conventional treatment combined with 0.01% hypochlorous acid on meibomian gland dysfunction[J]. Journal of Xuzhou Medical University, 2022, 42(7): 503-507. DOI: 10.3969/j.issn.2096-3882.2022.07.007

    常规治疗联合0.01%次氯酸治疗睑板腺功能障碍的临床观察

    Clinical observation of conventional treatment combined with 0.01% hypochlorous acid on meibomian gland dysfunction

    • 摘要: 目的观察常规治疗联合0.01%次氯酸眼用冲洗剂清洁睑缘治疗中重度睑板腺功能障碍(MGD)的睑板腺功能相关指标变化情况。方法选取2021年5月—2021年7月于徐州医科大学附属医院确诊为MGD 的患者,共90例90眼,随机分为2组 (n=45)。对照组予热敷、睑板腺按摩及0.3%玻璃酸钠滴眼液治疗;研究组在对照组的基础上加用0.01%次氯酸眼用冲洗剂清洁睑缘治疗。2组患者治疗前后评估眼表疾病指数量表(OSDI)评分,测量非接触式泪河高度(NITMH)、非侵入性首次泪膜破裂时间(NIBUTf)、非侵入性平均泪膜破裂时间(NIBUTav ),行脂质层分析、睑板腺缺失评估、睑缘充血程度评估及睑板腺分泌物性状检查。观察2组间及组内患者治疗前与治疗后1周、2周、1个月、3个月睑板腺功能相关指标的变化情况。结果与对照组相比,研究组治疗后2周、3个月的NITMH、脂质层分析和睑缘充血程度,治疗后1个月、3个月的NIBUTf,治疗后2周、1个月、3个月的OSDI评分和NIBUTav,治疗后各个时间点睑板腺分泌物性状的差异均有统计学意义(P<0.05)。结论常规治疗联合应用 0.01%次氯酸清洁睑缘可明显减轻MGD患者的症状及体征,改善泪膜稳定性,具有良好的应用前景。

       

      Abstract: ob<x>jective To investigate the changes of ocular surface and meibomian gland related parameters after combined with 0.01% hypochlorous acid to clean the palpebral marginal in the treatment of meibomian gland dysfunction (MGD). Methods A total of 90 patients with 90 eyes of who were diagnosed with MGD in our hospital from August 2021 to October 2021 were prospectively enrolled. They were randomly divided into 2 groups and underwent the Ocular surface disease Index (OSDI), non-invasive tear meniscus height (NITMH), non-invasive first tear film break-up time (NIBUTf), non-invasive average tear film break-up time (NIBUTav), lipid la<x>yer analysis, meibomian gland loss score(total upper and lower eyelid score), the degree of eyelid margin hyperemia score and meibomian gland secretion score.The control group was treated with hot compresses, meibomian gland massage and 0.3% sodium hyaluronate eye drops for treatment of 45 cases (45 eyes).The study group was treated with 0.01% hypochlorous acid on the basis of the control group to clean the palpebral marginal of 45 cases (45 eyes). The changes of ocular surface and meibomian gland related parameters between the two groups and within the group were observed before treatment and 1 week, 2 weeks, 1 month and 3 months after treatment. Results Compared with the control group, NITMH, lipid la<x>yer analysis,the degree of eyelid margin hyperemia , NIBUTf at 1 and 3 months after treatment, NIBUTav at 2 weeks, 1 month and 3 months after treatment, meibomian gland secretion at the same time point after treatment had statistical significance (P < 0.05). But there was no significant difference in OSDI and meibomian gland loss score at the same time point after treatment (P > 0.05). Compared with before treatment, there were statistically significant differences in the ocular surface and meibomian gland related parameters at each time point after treatment in the study group (P < 0.05). In the control group, OSDI, NITMH, NIBUTf, meibomian gland loss score, meibomian gland secretion at each time point after treatment, NIBUTav and lipid la<x>yer analysis at 2 weeks, 1 month and 3 months after treatment, and the degree of eyelid margin hyperemia at 1 week and 1 month after treatment had statistical significance (P < 0.05). Conclusion Conventional treatment combined with 0.01% hypochlorous acid cleaning palpebral marginal is effective in the treatment of MGD, which provides a new idea for the treatment of MGD.

       

    /

    返回文章
    返回